A phase 3 study of chemotherapy 1 pembrolizumab versus chemotherapy 1 placebo as first-line therapy for patients with advanced esophageal or esophagogastric junction (E/EGJ) cancer: KEYNOTE-590-Trial in progress

Author
Bhagia, P.
Zhu, Y.
Shah, S.
Doi, T.
Ozguroglu, M.
Kato, K.
Shah, M.
Enzinger, P.
Bennouna, J.
Shen, L.
Adenis, A.
Sun, J.
Cho, B.
Kojima, K.
Kostorov, V.
Hierro, C.
Metadata
Show full item record
URI
http://hdl.handle.net/20.500.12627/118673
Collections